149 general business jobs found in Chantilly, VA

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Managing Complexity. Improving Lives.

At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Managing Complexity. Improving Lives.

Developing innovative therapies is one of the most challenging, most essential and personally rewarding fields in science. Everything we do is led by our company values of integrity, being patient centric, taking ownership, delivering results and communicating openly. These values are essential to Astellas’ relationship with its employees. Our people humanize us, grow us, are the heart of everything we create and do with integrity. So bring your unique experience, perspective, thinking and ideas.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.